Shares of Guardion Health Sciences Inc (NASDAQ:GHSI) rose 8% during trading on Wednesday . The stock traded as high as $0.27 and last traded at $0.27, approximately 6,015,300 shares changed hands during mid-day trading. An increase of 256% from the average daily volume of 1,687,518 shares. The stock had previously closed at $0.25.

The firm has a fifty day simple moving average of $0.57. The company has a current ratio of 5.40, a quick ratio of 4.80 and a debt-to-equity ratio of 0.10.

Guardion Health Sciences (NASDAQ:GHSI) last released its earnings results on Monday, August 12th. The company reported ($0.14) EPS for the quarter. Guardion Health Sciences had a negative return on equity of 243.25% and a negative net margin of 780.75%. The company had revenue of $0.26 million during the quarter.

About Guardion Health Sciences (NASDAQ:GHSI)

Guardion Health Sciences, Inc, a specialty health sciences company, develops, formulates, and distributes condition-specific medical foods in the United States and internationally. It operates in two segments, Medical Foods and Vision Testing Diagnostics. The Medical Foods segment offers Lumega-Z, a medical food that replenishes and restores the macular protective pigment; MapcatSF, a medical device that measures the macular pigment optical density; and GlaucoCetin, a vision-specific medical food to support and protect the mitochondrial function of optic nerve cells, as well as improve blood flow in the ophthalmic artery in patients with glaucoma.

Featured Article: The Role of a Fiduciary and Individual Investors

Receive News & Ratings for Guardion Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Guardion Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.